0 Evaluaciones
ID

26002

Descripción

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT00434629

Link

https://clinicaltrials.gov/show/NCT00434629

Palabras clave

Versiones (2)
  1. 2/10/17 2/10/17 -
  2. 4/10/17 4/10/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

4 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility B-Cell Lymphoma NCT00434629

    Inglés

    Eligibility B-Cell Lymphoma NCT00434629

    1 formularios  
    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    cd20 positive b-cell lymphoma
    Descripción

    B-Cell Lymphoma CD20 antigen positive

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0079731
    UMLS CUI [1,2]
    C3888518
    confirmed relapsed/refractory disease following autologous transplant
    Descripción

    Autologous hematopoietic stem cell transplant | Recurrent disease | Refractory Disease

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C2193200
    UMLS CUI [2]
    C0277556
    UMLS CUI [3]
    C1514815
    age ≤ 75 years
    Descripción

    Age

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    performance status 0 or 1
    Descripción

    Performance status

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1518965
    creatinine ≤ 1.5 or calculated creatinine clearance ≥ 60 ml/min
    Descripción

    Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0201976
    UMLS CUI [2]
    C2711451
    total bilirubin, ast, and alt ≤ 1.5 x upper limit of normal (unless bilirubin due to gilbert's)
    Descripción

    Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Bilirubin Due to Gilbert Disease

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    UMLS CUI [2]
    C0201899
    UMLS CUI [3]
    C0201836
    UMLS CUI [4,1]
    C1705847
    UMLS CUI [4,2]
    C0005437
    UMLS CUI [4,3]
    C0678226
    UMLS CUI [4,4]
    C0017551
    no active cns disease
    Descripción

    CNS disorder Absent

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0007682
    UMLS CUI [1,2]
    C0332197
    no detectable bone marrow involvement by lymphoma on histopathologic bone marrow examination
    Descripción

    Lymphoma involves bone marrow Undetectable Bone Marrow Examination

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1301440
    UMLS CUI [1,2]
    C3827727
    UMLS CUI [1,3]
    C0005957
    bone marrow cellularity ≥ 15% on histopathologic bone marrow examination
    Descripción

    Bone marrow cellularity Percentage Bone Marrow Examination

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1561532
    UMLS CUI [1,2]
    C0439165
    UMLS CUI [1,3]
    C0005957
    availability of adequate stored autologous stem cell product (≥ 2 x 106 cd34+
    Descripción

    Stem cell product Autologous CD34 positive Availability

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1706452
    UMLS CUI [1,2]
    C0439859
    UMLS CUI [1,3]
    C0882849
    UMLS CUI [1,4]
    C0470187
    cells/kg)
    Descripción

    ID.11

    Tipo de datos

    boolean

    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    active infection
    Descripción

    Communicable Disease

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0009450
    pregnant woman are excluded from the study
    Descripción

    Pregnancy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    subjects not using contraceptives are excluded from the study
    Descripción

    Contraceptive methods Lacking

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0700589
    UMLS CUI [1,2]
    C0332268
    anc ≤ 1,500/μl and/or platelet count ≤ 100,000/μl
    Descripción

    Absolute neutrophil count | Platelet Count measurement

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0948762
    UMLS CUI [2]
    C0032181
    life expectancy of ≤ 2 months
    Descripción

    Life Expectancy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    prior anti-b-cell radioimmunotherapy (e.g., zevalin or bexxar) [patients who have received prior anti-b-cell monoclonal antibody therapy (e.g., rituximab or epratuzumab) will not be excluded.]
    Descripción

    Radioimmunotherapy Against B cells | Zevalin | Bexxar | Monoclonal Antibody Therapy Against B cells allowed | Rituximab allowed | Epratuzumab allowed

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0085101
    UMLS CUI [1,2]
    C0521124
    UMLS CUI [1,3]
    C0004561
    UMLS CUI [2]
    C0919274
    UMLS CUI [3]
    C0919272
    UMLS CUI [4,1]
    C0279694
    UMLS CUI [4,2]
    C0521124
    UMLS CUI [4,3]
    C0004561
    UMLS CUI [4,4]
    C0683607
    UMLS CUI [5,1]
    C0393022
    UMLS CUI [5,2]
    C0683607
    UMLS CUI [6,1]
    C1120776
    UMLS CUI [6,2]
    C0683607
    prior total body radiation therapy
    Descripción

    Total body radiation therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0948732
    positive human anti-mouse antibody (hama) testing
    Descripción

    Human anti-mouse antibody test Positive

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1868744
    UMLS CUI [1,2]
    C1514241
    Volver a la parte superior de la página

    Similar models

    Eligibility B-Cell Lymphoma NCT00434629

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    B-Cell Lymphoma CD20 antigen positive
    Item
    cd20 positive b-cell lymphoma
    boolean
    C0079731 (UMLS CUI [1,1])
    C3888518 (UMLS CUI [1,2])
    Autologous hematopoietic stem cell transplant | Recurrent disease | Refractory Disease
    Item
    confirmed relapsed/refractory disease following autologous transplant
    boolean
    C2193200 (UMLS CUI [1])
    C0277556 (UMLS CUI [2])
    C1514815 (UMLS CUI [3])
    Age
    Item
    age ≤ 75 years
    boolean
    C0001779 (UMLS CUI [1])
    Performance status
    Item
    performance status 0 or 1
    boolean
    C1518965 (UMLS CUI [1])
    Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula
    Item
    creatinine ≤ 1.5 or calculated creatinine clearance ≥ 60 ml/min
    boolean
    C0201976 (UMLS CUI [1])
    C2711451 (UMLS CUI [2])
    Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Bilirubin Due to Gilbert Disease
    Item
    total bilirubin, ast, and alt ≤ 1.5 x upper limit of normal (unless bilirubin due to gilbert's)
    boolean
    C1278039 (UMLS CUI [1])
    C0201899 (UMLS CUI [2])
    C0201836 (UMLS CUI [3])
    C1705847 (UMLS CUI [4,1])
    C0005437 (UMLS CUI [4,2])
    C0678226 (UMLS CUI [4,3])
    C0017551 (UMLS CUI [4,4])
    CNS disorder Absent
    Item
    no active cns disease
    boolean
    C0007682 (UMLS CUI [1,1])
    C0332197 (UMLS CUI [1,2])
    Lymphoma involves bone marrow Undetectable Bone Marrow Examination
    Item
    no detectable bone marrow involvement by lymphoma on histopathologic bone marrow examination
    boolean
    C1301440 (UMLS CUI [1,1])
    C3827727 (UMLS CUI [1,2])
    C0005957 (UMLS CUI [1,3])
    Bone marrow cellularity Percentage Bone Marrow Examination
    Item
    bone marrow cellularity ≥ 15% on histopathologic bone marrow examination
    boolean
    C1561532 (UMLS CUI [1,1])
    C0439165 (UMLS CUI [1,2])
    C0005957 (UMLS CUI [1,3])
    Stem cell product Autologous CD34 positive Availability
    Item
    availability of adequate stored autologous stem cell product (≥ 2 x 106 cd34+
    boolean
    C1706452 (UMLS CUI [1,1])
    C0439859 (UMLS CUI [1,2])
    C0882849 (UMLS CUI [1,3])
    C0470187 (UMLS CUI [1,4])
    ID.11
    Item
    cells/kg)
    boolean
    Item Group
    C0680251 (UMLS CUI)
    Communicable Disease
    Item
    active infection
    boolean
    C0009450 (UMLS CUI [1])
    Pregnancy
    Item
    pregnant woman are excluded from the study
    boolean
    C0032961 (UMLS CUI [1])
    Contraceptive methods Lacking
    Item
    subjects not using contraceptives are excluded from the study
    boolean
    C0700589 (UMLS CUI [1,1])
    C0332268 (UMLS CUI [1,2])
    Absolute neutrophil count | Platelet Count measurement
    Item
    anc ≤ 1,500/μl and/or platelet count ≤ 100,000/μl
    boolean
    C0948762 (UMLS CUI [1])
    C0032181 (UMLS CUI [2])
    Life Expectancy
    Item
    life expectancy of ≤ 2 months
    boolean
    C0023671 (UMLS CUI [1])
    Radioimmunotherapy Against B cells | Zevalin | Bexxar | Monoclonal Antibody Therapy Against B cells allowed | Rituximab allowed | Epratuzumab allowed
    Item
    prior anti-b-cell radioimmunotherapy (e.g., zevalin or bexxar) [patients who have received prior anti-b-cell monoclonal antibody therapy (e.g., rituximab or epratuzumab) will not be excluded.]
    boolean
    C0085101 (UMLS CUI [1,1])
    C0521124 (UMLS CUI [1,2])
    C0004561 (UMLS CUI [1,3])
    C0919274 (UMLS CUI [2])
    C0919272 (UMLS CUI [3])
    C0279694 (UMLS CUI [4,1])
    C0521124 (UMLS CUI [4,2])
    C0004561 (UMLS CUI [4,3])
    C0683607 (UMLS CUI [4,4])
    C0393022 (UMLS CUI [5,1])
    C0683607 (UMLS CUI [5,2])
    C1120776 (UMLS CUI [6,1])
    C0683607 (UMLS CUI [6,2])
    Total body radiation therapy
    Item
    prior total body radiation therapy
    boolean
    C0948732 (UMLS CUI [1])
    Human anti-mouse antibody test Positive
    Item
    positive human anti-mouse antibody (hama) testing
    boolean
    C1868744 (UMLS CUI [1,1])
    C1514241 (UMLS CUI [1,2])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial